Molecular patterns of multidrug resistance of Mycobacterium tuberculosis in Georgia

被引:10
|
作者
Shubladze, N. [1 ]
Tadumadze, N. [1 ]
Bablishvili, N. [1 ]
机构
[1] Natl Ctr TB & Lung Dis, Tbilisi, Georgia
关键词
M; tuberculosis; Mutation; Multidrug resistant tuberculosis; GenoType((R))MTBDRplus; Fitness cost;
D O I
10.1016/j.ijmyco.2013.02.002
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Tuberculosis (TB) infections caused by multidrug-resistant Mycobacterium tuberculosis (MDR MTB) remain a significant public health concern worldwide. Georgia has a high prevalence of MDR MTB. The genetic mechanisms underlying the emergence of MDR MTB strains in this region are poorly understood and need to be determined for developing better strategies for TB control. This study investigated the frequency of major drug resistance mutations across rpoB, katG and inhA loci of Georgian MDR MTB strains and explored differences between new and previously treated patients. A total of 634 MTB strains were examined for which an MDR phenotype had been previously determined by the proportions method. The Geno Type((R))MTBDRplus system was applied to screen the strains for the presence of rpoB (S531L, H526D, H526Y, and D516V), katG (S315T) and inhA promoter region (C15T and T8C) mutations. The target loci were amplified by PCR and then hybridized with the respective site-specific and wild type (control) probes. Results: Out of the 634 isolates tested considered by phenotypic testing to be resistant to RIF and INH, this resistance was confirmed by the GenoType((R))MTBDRplus assay in 575 (90.7%) isolates. RIF resistance was seen in 589 (92.9%) and INH resistance was seen in 584 (92.1%); 67.2% and 84.3% of MDR strains harbored respectively rpoB S531L and katG S315T mutations (generally known as having low or no fitness cost in MTB). The inhA C15T mutation was detected in 22.6% of the strains, whereas rpoB H526D, rpoB H526Y, rpoB D516V and inhA T8C were revealed at a markedly lower frequency (<= 5.2%). The specific mutations responsible for the RIF resistance of 110 isolates (17.4%) could not be detected as no corresponding mutant probe was indicated in the assay. There was no specific association of the presence of mutations with the gender/age groups. All types of prevailing mutations had higher levels in new cases. A great majority of the Georgian MDR MTB strains have a strong preference for the drug resistance mutations carrying no or low fitness cost. Thus, it can be suggested that MDR MTB strains with such mutations will continue to arise in Georgia at a high frequency even in the absence of antibiotic pressure. (C) 2013 Asian-African Society for Mycobacteriology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:73 / 78
页数:6
相关论文
共 50 条
  • [31] Pyrazinamide resistance in multidrug-resistant Mycobacterium tuberculosis isolates in Japan
    Ando, H.
    Mitarai, S.
    Kondo, Y.
    Suetake, T.
    Sekiguchi, J. -I.
    Kato, S.
    Mori, T.
    Kirikae, T.
    CLINICAL MICROBIOLOGY AND INFECTION, 2010, 16 (08) : 1164 - 1168
  • [32] Pyrazinamide Resistance and pncA Mutation Profiles in Multidrug Resistant Mycobacterium Tuberculosis
    Shi, Dawei
    Zhou, Qiulong
    Xu, Sihong
    Zhu, Yumei
    Li, Hui
    Xu, Ye
    INFECTION AND DRUG RESISTANCE, 2022, 15 : 4985 - 4994
  • [33] Molecular characterization and drug resistance patterns of Mycobacterium tuberculosis complex in extrapulmonary tuberculosis patients in Addis Ababa, Ethiopia
    Diriba, Getu
    Kebede, Abebaw
    Tola, Habteyes Hailu
    Yenew, Bazezew
    Moga, Shewki
    Addise, Desalegn
    Alemu, Ayinalem
    Mohammed, Zemedu
    Getahun, Muluwork
    Fantahun, Mengistu
    Tadesse, Mengistu
    Dagne, Biniyam
    Amare, Misikir
    Assefa, Gebeyehu
    Abera, Dessie
    Desta, Kassu
    PLOS ONE, 2020, 15 (12):
  • [34] A comparative study of antibiotic resistance patterns in Mycobacterium tuberculosis
    Serajian, Mohammadali
    Testagrose, Conrad
    Prosperi, Mattia
    Boucher, Christina
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [35] Drug resistance patterns of Mycobacterium tuberculosis complex and risk factors associated with multidrug-resistant tuberculosis in the upper southern part of Thailand
    Boonrod, Tum
    Ingsrisawang, Lily
    Pungrassami, Petchawan
    Sengsong, Supattra
    Bromnavej, Arisa
    Waseewiwat, Pinkamon
    Sreevijit, Natthapakam
    Bunsanong, Bunrit
    Bunsin, Chusri
    EPIDEMIOLOGY BIOSTATISTICS AND PUBLIC HEALTH, 2019, 16 (03)
  • [36] Molecular Characterization of Multidrug-Resistant Mycobacterium tuberculosis Isolated in Nepal
    Poudel, Ajay
    Nakajima, Chie
    Fukushima, Yukari
    Suzuki, Haruka
    Pandey, Basu Dev
    Maharjan, Bhagwan
    Suzuki, Yasuhiko
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (06) : 2831 - 2836
  • [37] Molecular epidemiology of multidrug-resistant Mycobacterium tuberculosis in Eastern Taiwan
    Hsu, A-H.
    Lin, C-B.
    Lee, Y-S.
    Chiang, C. Y.
    Chen, L-K.
    Tsai, Y-S.
    Lee, J-J
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2010, 14 (07) : 924 - 926
  • [38] Molecular analysis of multidrug resistant Mycobacterium tuberculosis isolates from Morocco
    Sabouni, Radia
    Kourout, Moussa
    Chaoui, Imane
    Jordaan, Annemarie
    Akrim, Mohammed
    Victor, Thomas C.
    Filali, Karim Maltouf
    El Mzibri, Mohammed
    Lahloui, Ouafae
    El Aouad, Rajae
    ANNALS OF MICROBIOLOGY, 2008, 58 (04) : 749 - 754
  • [39] Molecular analysis of bedaquiline resistance and genetic variations in clinical isolates of multidrug and fluoroquinolones-resistant Mycobacterium tuberculosis
    Nehru, Vijayalakshmi Jawaharlal
    Brammacharry, Usharani
    Ramkumar, S. R. Sri
    Khusro, Ameer
    Vadakunnel, Maria Jose
    Gunasekaran, Shoba
    David, Esther
    Priya, Veeraraghavan Vishnu
    Aljowaie, Reem M.
    Almutairi, Saeedah Musaed
    JOURNAL OF KING SAUD UNIVERSITY SCIENCE, 2024, 36 (06)
  • [40] Phenotypic and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Ningbo, China
    Yang Che
    Dingyi Bo
    Xiang Lin
    Tong Chen
    Tianfeng He
    Yi Lin
    BMC Infectious Diseases, 21